Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-29

Clinical Trial Update: Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD

View source ↗

Summary

An observational, multi-center study in rheumatoid arthritis patients with inadequate response or intolerance to conventional DMARDs who are starting a new biol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aqtual, Inc. | Conditions: Rheumatoid Arthritis | Status: RECRUITING